Today's biopharmaceutical labs and manufacturing operations demand robust applications to facilitate the discovery, refinement, and production of the latest miracle drugs. These applications automate the often tedious tasks that regulatory agencies demand, enabling you to focus on what you do best.

Nowhere is this need for automation more apparent than with the rigorous recordkeeping requirements of 21 CFR Part 11. These FDA regulations, designed to permit the widest possible use of electronic technology for maintaining electronic records, electronic signatures, and handwritten signatures executed to electronic records, describe in detail the types of controls required to leave behind the paper world.

Teradata can help your company meet its Part 11 obligations by offering a relational database management system that addresses all aspects of the regulation that a database product can meet.

Learn more about how Teradata Database gives you the flexibility to implement data collection and analysis applications with the confidence that the underlying database will not hinder compliance efforts.